StriVectin is a leading skincare company specializing in scientifically formulated and clinically proven products designed to address aging and changing skin. The company serves a diverse clientele, including individuals of all skin types, tones, and ages, who seek effective solutions for concerns such as wrinkles, fine lines, acne, and skin tightening. Operating in the global skincare market, StriVectin leverages advanced technologies, including AI-powered peptides and patented Niacin technology, to deliver visible skin transformations. The business model is primarily direct-to-consumer, with products available for purchase through their website and various retail partners. Revenue is generated through the sale of a wide range of skincare products, including moisturizers, serums, eye creams, and specialized collections like the Advanced Retinol and Anti-Wrinkle lines. StriVectin's commitment to scientific integrity and biomedical research has established it as a trusted name in the skincare industry for over 20 years.

Keywords: skincare, anti-aging, peptides, Niacin technology, AI-powered, retinol, acne treatment, clinically proven, direct-to-consumer, biomedical research.